Journal of Cellular and Molecular Pharmacology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • J Cell Mol Pharmacol 2023, Vol 7(5): 175

Spare Receptors and Drug Design Maximizing Therapeutic Benefit

Branca Vlaming*
Department of Theoretical Chemistry, Amsterdam Institute of Molecular and Life Sciences (AIMSS), Amsterdam Center for Multiscale Modeling (ACMM), Vrije Universiteit Amsterdam, The Netherlands
*Corresponding Author : Branca Vlaming, Department of Theoretical Chemistry, Amsterdam Institute of Molecular and Life Sciences (AIMSS), Amsterdam Center for Multiscale Modeling (ACMM), Vrije Universiteit Amsterdam, The Netherlands, Email: branca.vlaming@gmail.com

Received Date: Oct 01, 2023 / Published Date: Oct 30, 2023

Abstract

The landscape of drug design is undergoing a transformative shift with the recognition of spare receptors, challenging the traditional paradigm of full receptor occupancy for maximal therapeutic efficacy. Spare receptors, also known as constitutive activity or receptor reserve, represent a reservoir of untapped potential in drug development. This article explores the role of spare receptors in pharmacodynamics, emphasizing their impact on cellular signaling pathways and the opportunities they present for maximizing therapeutic benefit. By reconceptualizing the relationship between receptor occupancy and biological response, spare receptors offer a nuanced understanding that can lead to more targeted and efficient drug design. The discussion navigates through the challenges and opportunities associated with spare receptors and envisions their role in shaping the future of precision medicine and personalized drug therapies.

Citation: Vlaming B (2023) Spare Receptors and Drug Design MaximizingTherapeutic Benefit. J Cell Mol Pharmacol 7: 175.

Copyright: © 2023 Vlaming B. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top